Lupus & Connective Tissue Diseases
Feature
Voclosporin linked to threefold increase in lupus nephritis remission
The investigational calcineurin inhibitor has met all its 24- and 48-week endpoints in the phase IIb AURA-LV trial, according to Aurinia...
From the Journals
Connective tissue diseases reported in patients receiving immune checkpoint inhibitors
For the first time, new-onset connective tissue disease has been reported in patients who were treated with anti-PD1/PDL-1 agents, according to...
From the Journals
Pediatric lupus patients face large burden of serious infection
Children with systemic lupus erythematosus have high rates of serious infections requiring hospitalization, especially those with lupus nephritis...
From the Journals
Sarcoidosis doubles hospitalized infection risk
Sarcoidosis was associated with double the risk of hospitalization due to infection in a population-based cohort study that also found the use of...
From the Journals
Annual nailfold videocapillaroscopy found prognostic in systemic sclerosis
Features of nailfold videocapillaroscopy in systemic sclerosis patients can be used to predict overall disease progression over the course of...
From the Journals
Comparison of immunosuppressants for early diffuse systemic sclerosis yields mixed results
In this observational study with standardized protocols for different immunosuppressants, investigators attempt to determine which ones favorably...
Conference Coverage
Hypertension in SLE pregnancy: Is it lupus flare or preeclampsia?
SNOWMASS, COLO. – There are useful blood tests that can augment clinical decision making in distinguishing a flare of systemic lupus erythematosus...
Conference Coverage
Rituximab is dramatically effective in IgG4-related disease
SNOWMASS, COLO. – If glucocorticoids do not bring patients with immunoglobulin G4-related disease into long-term sustained remission, B cell...
Conference Coverage
IgG4-related disease can strike any organ system
SNOWMASS, COLO. – John H. Stone, MD, describes how, within the past decade, substantial progress has been made in identifying immunoglobulin G4-...
From the Journals
New CF guidelines include lower sweat chloride threshold
Updated guidelines for the diagnosis and treatment of cystic fibrosis (CF) include two major changes.The first important update is that clinicians...
From the Journals
Hydroxychloroquine dosing guidelines have little impact in clinical practice
A substantial number of rheumatology patients are receiving excess starting and maintenance doses of hydroxychloroquine despite the existence of...